Alcon
| Company type | Public |
|---|---|
| Industry | Eye care |
| Founded | 1945 |
| Headquarters | Switzerland |
Key people | David Endicott (CEO) |
| Products |
|
| Revenue | US$9.91 billion (2024) |
Number of employees | 25,599 (2024) |
| Website | www |
Alcon Inc. is a Swiss-American company that makes products for eye care. It was founded in 1945 in Fort Worth, Texas, and is now based in Geneva, Switzerland.
Alcon produces contact lenses, eye surgery equipment, and eye drops. It operates in over 75 countries and sells products in more than 180 countries.
Alcon was part of Novartis until 2019, when it became an independent public company. In 2022, it bought Aerie Pharmaceuticals, and in 2025, it agreed to buy LENSAR to expand its surgical portfolio.